ArticleJournal of experimental & clinical cancer research : CR2018

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.

Baojin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.